LACOPAZOLE

This brand name is authorized in Nigeria.

Active ingredients

The drug LACOPAZOLE contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5012	Tablet	LACOPAZOLE TABLETS TAB 400 mg 11	LACOPAZOLE TABLETS ALBENDAZOLE 400mg EACH TABLET CONTAINS ALEBDAZOLE USP 400mg, Excipients actose monohydrate, magnesium stearate, microcrystalline cellulose, povidone A4-5012 Drugs Imported Products 11 Prescription Only Medicine (POM) 23/09/2020 JIMMI-WELL INTERNATIONAL COMPANY LIMITED, No. 5 Abazuonu Street, Iyiowa Odekpe, Onitsha, Anambra State, Nigeria 80370704 jimmipharm@gmail.com CIRON DRUGS & PHARMA PVT. LTD., 35-37, 43-45 DEWAN UDYOG NAGAR, ALIYALI, PALGHAR DIST. THANE 401404 INDIA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5012